[go: up one dir, main page]

NO20040113L - Variolinderivater og deres anvendelse som antitumormidler - Google Patents

Variolinderivater og deres anvendelse som antitumormidler

Info

Publication number
NO20040113L
NO20040113L NO20040113A NO20040113A NO20040113L NO 20040113 L NO20040113 L NO 20040113L NO 20040113 A NO20040113 A NO 20040113A NO 20040113 A NO20040113 A NO 20040113A NO 20040113 L NO20040113 L NO 20040113L
Authority
NO
Norway
Prior art keywords
substituted
antitumor agents
unsubstituted
groups
alkynyl
Prior art date
Application number
NO20040113A
Other languages
English (en)
Other versions
NO328848B1 (no
Inventor
Carmen Cuevas
Andres Francesch
Ignacio Manzanares
Simon Munt
Modesto Remuinan
Juan Jose Gonzalez
Carlos Del Pozo
Regan James Anderson
Jonathan Charles Morris
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20040113L publication Critical patent/NO20040113L/no
Publication of NO328848B1 publication Critical patent/NO328848B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20040113A 2001-07-11 2004-01-12 Variolinderivater og deres anvendelse som antitumormidler NO328848B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116966.3A GB0116966D0 (en) 2001-07-11 2001-07-11 Anittumoral compounds
PCT/GB2002/003197 WO2003006457A1 (en) 2001-07-11 2002-07-11 Variolin derivatives and their use as antitumor agents

Publications (2)

Publication Number Publication Date
NO20040113L true NO20040113L (no) 2004-03-09
NO328848B1 NO328848B1 (no) 2010-05-31

Family

ID=9918335

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040113A NO328848B1 (no) 2001-07-11 2004-01-12 Variolinderivater og deres anvendelse som antitumormidler

Country Status (19)

Country Link
US (2) US7495000B2 (no)
EP (2) EP1867645B1 (no)
JP (1) JP4369225B2 (no)
KR (1) KR100929616B1 (no)
CN (1) CN1553906B (no)
AT (2) ATE396987T1 (no)
AU (1) AU2002317329B2 (no)
CA (1) CA2453418C (no)
DE (2) DE60237652D1 (no)
ES (2) ES2307768T3 (no)
GB (1) GB0116966D0 (no)
HU (1) HUP0402658A2 (no)
IL (2) IL159792A0 (no)
MX (1) MXPA04000355A (no)
NO (1) NO328848B1 (no)
NZ (1) NZ530556A (no)
PL (1) PL366894A1 (no)
RU (1) RU2302419C2 (no)
WO (1) WO2003006457A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1299388T3 (da) 2000-07-11 2009-08-31 Pharma Mar Sa Variolin-derivater som anti-cancermidler
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) * 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds
DK2300475T3 (en) * 2008-06-11 2014-12-08 Genentech Inc Diazacarbazoler and methods of using
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1299388T3 (da) 2000-07-11 2009-08-31 Pharma Mar Sa Variolin-derivater som anti-cancermidler
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds

Also Published As

Publication number Publication date
NO328848B1 (no) 2010-05-31
US7495000B2 (en) 2009-02-24
ES2307768T3 (es) 2008-12-01
US20060235223A1 (en) 2006-10-19
KR20040023649A (ko) 2004-03-18
GB0116966D0 (en) 2001-09-05
CN1553906B (zh) 2010-04-28
NZ530556A (en) 2005-07-29
IL159792A (en) 2009-08-03
HK1060354A1 (en) 2004-08-06
KR100929616B1 (ko) 2009-12-03
MXPA04000355A (es) 2005-03-07
RU2004103857A (ru) 2005-06-20
JP4369225B2 (ja) 2009-11-18
DE60237652D1 (de) 2010-10-21
ATE396987T1 (de) 2008-06-15
IL159792A0 (en) 2004-06-20
PL366894A1 (en) 2005-02-07
JP2004536850A (ja) 2004-12-09
ATE480533T1 (de) 2010-09-15
US7772241B2 (en) 2010-08-10
EP1404668A1 (en) 2004-04-07
WO2003006457A1 (en) 2003-01-23
CA2453418A1 (en) 2003-01-23
EP1404668B1 (en) 2008-05-28
EP1867645A1 (en) 2007-12-19
RU2302419C2 (ru) 2007-07-10
EP1867645B1 (en) 2010-09-08
US20090197901A1 (en) 2009-08-06
CA2453418C (en) 2011-05-17
AU2002317329B2 (en) 2008-10-02
HUP0402658A2 (hu) 2005-04-28
ES2354991T3 (es) 2011-03-21
DE60226869D1 (de) 2008-07-10
CN1553906A (zh) 2004-12-08

Similar Documents

Publication Publication Date Title
MXPA04001240A (es) Analogos antitumorales.
UY26899A1 (es) Derivados de pirazol fusionados
NO20012617D0 (no) Kinolin- og kinzolinderivater
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
DK1382604T3 (da) Quinolinderivater med en azolylgruppe og quinazolinderivater
DE69418704D1 (de) Anthranilsäure derivate
CY1113359T1 (el) Αντι-νεοπλασιακα παραγωγα του et-743
CY1109283T1 (el) Παραγωγα βαριολινης ως αντικαρκινικα μεσα
MXPA02006329A (es) 8-arilquinolinas sustituidas que son inhibidores de fosfodiesterasa-4.
DK1086096T3 (da) Benzamider med tetrahydrofuranyloxy-substituenter som inhibitorer af phosphodiesterase 4
DK1847534T3 (da) Thiadiazolin-derivater til behandling af kræft
NO20040113L (no) Variolinderivater og deres anvendelse som antitumormidler
NO985685L (no) Dibenzo-oksazepin- og -dioksazepin-derivater og deres anvendelse som anti-tumormidler
HUP0402149A2 (hu) Vízoldható fenil-piridazin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
DE60116855D1 (de) Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität
DK1532139T3 (da) Totalsyntese af myriaporoner
DE60230924D1 (de) 2-substituierte vitamin-d-derivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees